Nantong Jinghua Pharmaceutical Co Ltd (002349) — Strategic Asset Allocation Index
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Strategic Asset Allocation Index of 24.3% as of September 2023. Strategic assets (PP&E of CN¥669.19 Million plus long-term investments of CN¥-) total CN¥669.19 Million, measured against net assets of CN¥2.75 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Nantong Jinghua Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Nantong Jinghua Pharmaceutical Co Ltd Strategic Asset Allocation Index (2006–2022)
This chart shows how Nantong Jinghua Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of September 2023, the index stands at 24.3%, representing strategic assets of CN¥669.19 Million against net assets of CN¥2.75 Billion CNY. See Nantong Jinghua Pharmaceutical Co Ltd (002349) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Nantong Jinghua Pharmaceutical Co Ltd (2006–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Nantong Jinghua Pharmaceutical Co Ltd (002349) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 27.0% | CN¥708.42 Million | CN¥708.42 Million | CN¥- | CN¥2.62 Billion | ▼ -18.5 pp |
| 2021 | 45.5% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.57 Billion | ▼ -3.2 pp |
| 2020 | 48.7% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥2.49 Billion | ▼ -10.6 pp |
| 2019 | 59.3% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥2.15 Billion | ▲ +9.6 pp |
| 2018 | 49.7% | CN¥1.34 Billion | CN¥1.22 Billion | CN¥117.27 Million | CN¥2.69 Billion | ▲ +5.9 pp |
| 2017 | 43.8% | CN¥1.16 Billion | CN¥1.04 Billion | CN¥115.97 Million | CN¥2.65 Billion | ▲ +7.3 pp |
| 2016 | 36.5% | CN¥840.83 Million | CN¥713.14 Million | CN¥127.69 Million | CN¥2.30 Billion | ▲ +5.3 pp |
| 2015 | 31.2% | CN¥697.90 Million | CN¥551.86 Million | CN¥146.04 Million | CN¥2.23 Billion | ▼ 0.0 pp |
| 2014 | 31.2% | CN¥479.53 Million | CN¥479.53 Million | CN¥- | CN¥1.53 Billion | ▼ -36.3 pp |
| 2013 | 67.5% | CN¥500.80 Million | CN¥500.80 Million | CN¥- | CN¥741.83 Million | ▲ +17.3 pp |
| 2012 | 50.2% | CN¥358.86 Million | CN¥358.86 Million | CN¥- | CN¥714.87 Million | ▲ +24.0 pp |
| 2011 | 26.2% | CN¥166.59 Million | CN¥166.59 Million | CN¥- | CN¥636.30 Million | ▲ +8.7 pp |
| 2010 | 17.5% | CN¥95.24 Million | CN¥95.24 Million | CN¥- | CN¥544.45 Million | ▼ -50.9 pp |
| 2009 | 68.4% | CN¥93.75 Million | CN¥93.75 Million | CN¥- | CN¥137.11 Million | ▼ -5.5 pp |
| 2008 | 73.9% | CN¥87.70 Million | CN¥87.70 Million | CN¥- | CN¥118.66 Million | ▼ -30.5 pp |
| 2007 | 104.5% | CN¥95.95 Million | CN¥95.95 Million | CN¥- | CN¥91.86 Million | ▼ -44.9 pp |
| 2006 | 149.4% | CN¥104.57 Million | CN¥104.57 Million | CN¥- | CN¥70.00 Million | — |